新生児スクリーニングの世界市場見通し:新生児聴力スクリーニング装置、パルスオキシメーター、新生児異常スクリーニング装置、試薬、アッセイキット

Stratistics MRCが出版した調査資料(SMRC611029)
◆英語タイトル:Newborn Screening - Global Market Outlook (2016-2022)
◆商品コード:SMRC611029
◆発行会社(調査会社):Stratistics MRC
◆発行日:2016年10月
◆ページ数:131
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥456,500見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥577,500見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、新生児スクリーニングの世界市場について調査・分析し、新生児スクリーニングの世界市場規模、市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
・エグゼクティブサマリー
・序文
・新生児スクリーニングの世界市場:市場動向分析
・新生児スクリーニングの世界市場:競争要因分析
・新生児スクリーニングの世界市場:セグメント別分析/市場規模
・新生児スクリーニングの世界市場:地域別分析/市場規模
・新生児スクリーニングの北米市場規模
・新生児スクリーニングの欧州市場規模
・新生児スクリーニングのアジア市場規模
・新生児スクリーニングの世界市場:主な市場開拓
・関連企業分析
【レポートの概要】

According to Stratistics MRC, the Global Newborn Screening market is accounted for $495.50 million in 2015 and is expected to reach $1,307.65 million by 2022 growing at a CAGR of 12.9%. In present scenario the Newborn baby is either being affected by the environmental conditions or born with some disorder, and hence the Newborn Screening market is helping out to detect those disorders. Recent technological advancements, government legislation & support, increasing awareness among people have given impetus to the market. However, Socio-Economic barriers and less trained professionals are some of the factors hindering the growth.

Tandem Mass Spectrometry (TMS) segment is expected to account for highest CAGR, attributing to its time & cost effectiveness of the technology compared to other technologies available in this particular market. In addition to this, Dry Blood Spot Test type segment is expected to be the largest market owing to the technological advancements due to which new and advanced products are being launched in the market. North America is dominating the global market in order to the increasing prevalence of cardiovascular disorders and enforced testing. However, Asia Pacific is expected to present lenient growth, poised by the favorable healthcare.

Some of the key players of the Newborn Screening market include AB Sciex LLC, Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Covidien PLC, GE Healthcare, GE Lifesciences, Masimo Corporation, Natus Medical Incorporated, Perkinelmer, Inc., Trivitron Healthcare and Waters Corporation.

Product types Covered:
• Newborn Hearing Screening Instruments
o Hearing Screening Accessories
o Hearing Screening Devices
• Pulse Oximeters
• Newborn Disorder Screening Instruments
o Developmental
o Genetic
o Metabolic
• Reagents and Assay Kits

Technologies Covered:
• DNA-Based Assays
• Electrophoresis
• Hearing Screen Technology
• Immunoassays and Enzymatic Assays
• Pulse Oximetry Screening Technology
• Tandem Mass Spectrometry (TMS)

Test Types Covered:
• Critical Congenital Heart Diseases (CCHD) Test
• Dry Blood Spot Test
• Hearing Screen Test

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Emerging markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Newborn Screening market, By Product Type
5.1 Introduction
5.2 Newborn Hearing Screening Instruments
5.2.1 Hearing Screening Accessories
5.2.2 Hearing Screening Devices
5.3 Pulse Oximeters
5.4 Newborn Disorder Screening Instruments
5.4.1 Developmental
5.4.2 Genetic
5.4.3 Metabolic
5.5 Reagents and Assay Kits

6 Global Newborn Screening market, By Technology
6.1 Introduction
6.2 DNA-Based Assays
6.3 Electrophoresis
6.4 Hearing Screen Technology
6.5 Immunoassays and Enzymatic Assays
6.6 Pulse Oximetry Screening Technology
6.7 Tandem Mass Spectrometry (TMS)

7 Global Newborn Screening market, By Test Type
7.1 Introduction
7.2 Critical Congenital Heart Diseases (CCHD) Test
7.3 Dry Blood Spot Test
7.4 Hearing Screen Test

8 Global Newborn Screening market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 AB Sciex LLC
10.2 Agilent Technologies Inc.
10.3 Bio-Rad Laboratories, Inc.
10.4 Covidien PLC
10.5 GE Healthcare
10.6 GE Lifesciences
10.7 Masimo Corporation
10.8 Natus Medical Incorporated
10.9 Perkinelmer, Inc.
10.10 Trivitron Healthcare
10.11 Waters Corporation

List Of Tables
Table 1 Global Newborn Screening market, By Region (2013-2022) ($MN)
Table 2 Global Newborn Screening market, By Product Type (2013-2022) ($MN)
Table 3 Global Newborn Screening market, By Newborn Hearing Screening Instruments (2013-2022) ($MN)
Table 4 Global Newborn Screening market, By Hearing Screening Accessories (2013-2022) ($MN)
Table 5 Global Newborn Screening market, By Hearing Screening Devices (2013-2022) ($MN)
Table 6 Global Newborn Screening market, By Pulse Oximeters (2013-2022) ($MN)
Table 7 Global Newborn Screening market, By Newborn Disorder Screening Instruments (2013-2022) ($MN)
Table 8 Global Newborn Screening market, By Developmental (2013-2022) ($MN)
Table 9 Global Newborn Screening market, By Genetic (2013-2022) ($MN)
Table 10 Global Newborn Screening market, By Metabolic (2013-2022) ($MN)
Table 11 Global Newborn Screening market, By Reagents and Assay Kits (2013-2022) ($MN)
Table 12 Global Newborn Screening market, By Technology (2013-2022) ($MN)
Table 13 Global Newborn Screening market, By DNA-Based Assays (2013-2022) ($MN)
Table 14 Global Newborn Screening market, By Electrophoresis (2013-2022) ($MN)
Table 15 Global Newborn Screening market, By Hearing Screen Technology (2013-2022) ($MN)
Table 16 Global Newborn Screening market, By Immunoassays and Enzymatic Assays (2013-2022) ($MN)
Table 17 Global Newborn Screening market, By Pulse Oximetry Screening Technology (2013-2022) ($MN)
Table 18 Global Newborn Screening market, By Tandem Mass Spectrometry (TMS) (2013-2022) ($MN)
Table 19 Global Newborn Screening market, By Test Type (2013-2022) ($MN)
Table 20 Global Newborn Screening market, By Critical Congenital Heart Diseases (CCHD) Test (2013-2022) ($MN)
Table 21 Global Newborn Screening market, By Dry Blood Spot Test (2013-2022) ($MN)
Table 22 Global Newborn Screening market, By Hearing Screen Test (2013-2022) ($MN)
Table 23 North America Newborn Screening market, By Country (2013-2022) ($MN)
Table 24 North America Newborn Screening market, By Product Type (2013-2022) ($MN)
Table 25 North America Newborn Screening market, By Newborn Hearing Screening Instruments (2013-2022) ($MN)
Table 26 North America Newborn Screening market, By Hearing Screening Accessories (2013-2022) ($MN)
Table 27 North America Newborn Screening market, By Hearing Screening Devices (2013-2022) ($MN)
Table 28 North America Newborn Screening market, By Pulse Oximeters (2013-2022) ($MN)
Table 29 North America Newborn Screening market, By Newborn Disorder Screening Instruments (2013-2022) ($MN)
Table 30 North America Newborn Screening market, By Developmental (2013-2022) ($MN)
Table 31 North America Newborn Screening market, By Genetic (2013-2022) ($MN)
Table 32 North America Newborn Screening market, By Metabolic (2013-2022) ($MN)
Table 33 North America Newborn Screening market, By Reagents and Assay Kits (2013-2022) ($MN)
Table 34 North America Newborn Screening market, By Technology (2013-2022) ($MN)
Table 35 North America Newborn Screening market, By DNA-Based Assays (2013-2022) ($MN)
Table 36 North America Newborn Screening market, By Electrophoresis (2013-2022) ($MN)
Table 37 North America Newborn Screening market, By Hearing Screen Technology (2013-2022) ($MN)
Table 38 North America Newborn Screening market, By Immunoassays and Enzymatic Assays (2013-2022) ($MN)
Table 39 North America Newborn Screening market, By Pulse Oximetry Screening Technology (2013-2022) ($MN)
Table 40 North America Newborn Screening market, By Tandem Mass Spectrometry (TMS) (2013-2022) ($MN)
Table 41 North America Newborn Screening market, By Test Type (2013-2022) ($MN)
Table 42 North America Newborn Screening market, By Critical Congenital Heart Diseases (CCHD) Test (2013-2022) ($MN)
Table 43 North America Newborn Screening market, By Dry Blood Spot Test (2013-2022) ($MN)
Table 44 North America Newborn Screening market, By Hearing Screen Test (2013-2022) ($MN)
Table 45 Europe Newborn Screening market, By Country (2013-2022) ($MN)
Table 46 Europe Newborn Screening market, By Product Type (2013-2022) ($MN)
Table 47 Europe Newborn Screening market, By Newborn Hearing Screening Instruments (2013-2022) ($MN)
Table 48 Europe Newborn Screening market, By Hearing Screening Accessories (2013-2022) ($MN)
Table 49 Europe Newborn Screening market, By Hearing Screening Devices (2013-2022) ($MN)
Table 50 Europe Newborn Screening market, By Pulse Oximeters (2013-2022) ($MN)
Table 51 Europe Newborn Screening market, By Newborn Disorder Screening Instruments (2013-2022) ($MN)
Table 52 Europe Newborn Screening market, By Developmental (2013-2022) ($MN)
Table 53 Europe Newborn Screening market, By Genetic (2013-2022) ($MN)
Table 54 Europe Newborn Screening market, By Metabolic (2013-2022) ($MN)
Table 55 Europe Newborn Screening market, By Reagents and Assay Kits (2013-2022) ($MN)
Table 56 Europe Newborn Screening market, By Technology (2013-2022) ($MN)
Table 57 Europe Newborn Screening market, By DNA-Based Assays (2013-2022) ($MN)
Table 58 Europe Newborn Screening market, By Electrophoresis (2013-2022) ($MN)
Table 59 Europe Newborn Screening market, By Hearing Screen Technology (2013-2022) ($MN)
Table 60 Europe Newborn Screening market, By Immunoassays and Enzymatic Assays (2013-2022) ($MN)
Table 61 Europe Newborn Screening market, By Pulse Oximetry Screening Technology (2013-2022) ($MN)
Table 62 Europe Newborn Screening market, By Tandem Mass Spectrometry (TMS) (2013-2022) ($MN)
Table 63 Europe Newborn Screening market, By Test Type (2013-2022) ($MN)
Table 64 Europe Newborn Screening market, By Critical Congenital Heart Diseases (CCHD) Test (2013-2022) ($MN)
Table 65 Europe Newborn Screening market, By Dry Blood Spot Test (2013-2022) ($MN)
Table 66 Europe Newborn Screening market, By Hearing Screen Test (2013-2022) ($MN)
Table 67 Asia Pacific Newborn Screening market, By Country (2013-2022) ($MN)
Table 68 Asia Pacific Newborn Screening market, By Product Type (2013-2022) ($MN)
Table 69 Asia Pacific Newborn Screening market, By Newborn Hearing Screening Instruments (2013-2022) ($MN)
Table 70 Asia Pacific Newborn Screening market, By Hearing Screening Accessories (2013-2022) ($MN)
Table 71 Asia Pacific Newborn Screening market, By Hearing Screening Devices (2013-2022) ($MN)
Table 72 Asia Pacific Newborn Screening market, By Pulse Oximeters (2013-2022) ($MN)
Table 73 Asia Pacific Newborn Screening market, By Newborn Disorder Screening Instruments (2013-2022) ($MN)
Table 74 Asia Pacific Newborn Screening market, By Developmental (2013-2022) ($MN)
Table 75 Asia Pacific Newborn Screening market, By Genetic (2013-2022) ($MN)
Table 76 Asia Pacific Newborn Screening market, By Metabolic (2013-2022) ($MN)
Table 77 Asia Pacific Newborn Screening market, By Reagents and Assay Kits (2013-2022) ($MN)
Table 78 Asia Pacific Newborn Screening market, By Technology (2013-2022) ($MN)
Table 79 Asia Pacific Newborn Screening market, By DNA-Based Assays (2013-2022) ($MN)
Table 80 Asia Pacific Newborn Screening market, By Electrophoresis (2013-2022) ($MN)
Table 81 Asia Pacific Newborn Screening market, By Hearing Screen Technology (2013-2022) ($MN)
Table 82 Asia Pacific Newborn Screening market, By Immunoassays and Enzymatic Assays (2013-2022) ($MN)
Table 83 Asia Pacific Newborn Screening market, By Pulse Oximetry Screening Technology (2013-2022) ($MN)
Table 84 Asia Pacific Newborn Screening market, By Tandem Mass Spectrometry (TMS) (2013-2022) ($MN)
Table 85 Asia Pacific Newborn Screening market, By Test Type (2013-2022) ($MN)
Table 86 Asia Pacific Newborn Screening market, By Critical Congenital Heart Diseases (CCHD) Test (2013-2022) ($MN)
Table 87 Asia Pacific Newborn Screening market, By Dry Blood Spot Test (2013-2022) ($MN)
Table 88 Asia Pacific Newborn Screening market, By Hearing Screen Test (2013-2022) ($MN)
Table 89 RoW Newborn Screening market, By Country (2013-2022) ($MN)
Table 90 RoW Newborn Screening market, By Product Type (2013-2022) ($MN)
Table 91 RoW Newborn Screening market, By Newborn Hearing Screening Instruments (2013-2022) ($MN)
Table 92 RoW Newborn Screening market, By Hearing Screening Accessories (2013-2022) ($MN)
Table 93 RoW Newborn Screening market, By Hearing Screening Devices (2013-2022) ($MN)
Table 94 RoW Newborn Screening market, By Pulse Oximeters (2013-2022) ($MN)
Table 95 RoW Newborn Screening market, By Newborn Disorder Screening Instruments (2013-2022) ($MN)
Table 96 RoW Newborn Screening market, By Developmental (2013-2022) ($MN)
Table 97 RoW Newborn Screening market, By Genetic (2013-2022) ($MN)
Table 98 RoW Newborn Screening market, By Metabolic (2013-2022) ($MN)
Table 99 RoW Newborn Screening market, By Reagents and Assay Kits (2013-2022) ($MN)
Table 100 RoW Newborn Screening market, By Technology (2013-2022) ($MN)
Table 101 RoW Newborn Screening market, By DNA-Based Assays (2013-2022) ($MN)
Table 102 RoW Newborn Screening market, By Electrophoresis (2013-2022) ($MN)
Table 103 RoW Newborn Screening market, By Hearing Screen Technology (2013-2022) ($MN)
Table 104 RoW Newborn Screening market, By Immunoassays and Enzymatic Assays (2013-2022) ($MN)
Table 105 RoW Newborn Screening market, By Pulse Oximetry Screening Technology (2013-2022) ($MN)
Table 106 RoW Newborn Screening market, By Tandem Mass Spectrometry (TMS) (2013-2022) ($MN)
Table 107 RoW Newborn Screening market, By Test Type (2013-2022) ($MN)
Table 108 RoW Newborn Screening market, By Critical Congenital Heart Diseases (CCHD) Test (2013-2022) ($MN)
Table 109 RoW Newborn Screening market, By Dry Blood Spot Test (2013-2022) ($MN)
Table 110 RoW Newborn Screening market, By Hearing Screen Test (2013-2022) ($MN)



【レポートのキーワード】

新生児スクリーニング、新生児聴力スクリーニング装置、パルスオキシメーター、新生児異常スクリーニング装置、試薬、アッセイキット

★調査レポート[新生児スクリーニングの世界市場見通し:新生児聴力スクリーニング装置、パルスオキシメーター、新生児異常スクリーニング装置、試薬、アッセイキット] (コード:SMRC611029)販売に関する免責事項を必ずご確認ください。
★調査レポート[新生児スクリーニングの世界市場見通し:新生児聴力スクリーニング装置、パルスオキシメーター、新生児異常スクリーニング装置、試薬、アッセイキット]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆